Operating Margin of Lexaria Bioscience Corp. from 31 Aug 2021 to 30 Nov 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lexaria Bioscience Corp. quarterly and annual Operating Margin in % history and change rate from 31 Aug 2021 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Operating Margin for the quarter ending 30 Nov 2025 was -2062%, a 40% decline year-over-year.
  • Lexaria Bioscience Corp. annual Operating Margin for 2025 was -1683%, a 36% decline from 2024.
  • Lexaria Bioscience Corp. annual Operating Margin for 2024 was -1239%, a 57% increase from 2023.
  • Lexaria Bioscience Corp. annual Operating Margin for 2023 was -2888%, a 11% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -2062% -592% -40% 01 Sep 2025 30 Nov 2025
Q3 2025 -1683% -444% -36% 01 Jun 2025 31 Aug 2025
Q2 2025 -1850% -715% -63% 01 Mar 2025 31 May 2025
Q1 2025 -1785% -470% -36% 01 Dec 2024 28 Feb 2025
Q4 2024 -1470% +667% +31% 01 Sep 2024 30 Nov 2024
Q3 2024 -1239% +1649% +57% 01 Jun 2024 31 Aug 2024
Q2 2024 -1135% 01 Mar 2024 31 May 2024
Q1 2024 -1315% 01 Dec 2023 29 Feb 2024
Q4 2023 -2137% 01 Sep 2023 30 Nov 2023
Q3 2023 -2888% 01 Jun 2023 31 Aug 2023

Lexaria Bioscience Corp. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 -1683% -444% -36% 01 Sep 2024 31 Aug 2025
2024 -1239% +1649% +57% 01 Sep 2023 31 Aug 2024
2023 -2888% -297% -11% 01 Sep 2022 31 Aug 2023
2022 -2592% -1805% -229% 01 Sep 2021 31 Aug 2022
2021 -787% 01 Sep 2020 31 Aug 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.